| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 202.258 | 278.356 | 250.084 | 376.921 | 383.418 | 2.062.471 | 747.008 | 860.883 | 909.021 | 571.224 |
| Total Income - EUR | 216.566 | 295.797 | 353.708 | 390.608 | 370.207 | 2.163.753 | 934.511 | 921.086 | 1.002.575 | 675.632 |
| Total Expenses - EUR | 199.675 | 294.800 | 346.083 | 385.087 | 363.658 | 1.290.636 | 848.506 | 896.135 | 975.750 | 648.723 |
| Gross Profit/Loss - EUR | 16.891 | 997 | 7.624 | 5.521 | 6.548 | 873.117 | 86.004 | 24.952 | 26.825 | 26.909 |
| Net Profit/Loss - EUR | 15.140 | 333 | 471 | 3.336 | 3.439 | 750.678 | 70.740 | 15.370 | 17.006 | 17.736 |
| Employees | 8 | 14 | 14 | 13 | 12 | 19 | 19 | 17 | 17 | 14 |
Check the financial reports for the company - Biocomp Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 37.825 | 259.931 | 254.025 | 231.376 | 251.884 | 450.902 | 422.760 | 368.793 | 326.579 | 330.230 |
| Current Assets | 27.561 | 110.002 | 110.182 | 126.730 | 120.695 | 606.745 | 634.190 | 646.533 | 638.541 | 675.997 |
| Inventories | 10.786 | 41.950 | 49.990 | 65.539 | 59.527 | 328.405 | 509.690 | 532.274 | 549.868 | 548.257 |
| Receivables | 6.624 | 31.079 | 54.669 | 47.945 | 50.808 | 81.280 | 92.642 | 110.633 | 74.036 | 121.101 |
| Cash | 10.151 | 36.973 | 5.523 | 13.246 | 10.360 | 197.059 | 31.858 | 3.627 | 14.637 | 6.640 |
| Shareholders Funds | 51.752 | 51.385 | 46.378 | 48.862 | 51.355 | 773.528 | 758.193 | 709.137 | 683.305 | 685.160 |
| Social Capital | 2.250 | 2.227 | 2.189 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 10.108 | 10.052 |
| Debts | 13.634 | 318.547 | 327.755 | 310.138 | 321.440 | 285.036 | 299.484 | 308.483 | 311.796 | 342.845 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.985 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Biocomp Srl